Pei Lin, MD
Anatomic Pathology & Clinical Pathology · Houston, TXNPI 1912004680
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,400 of the $7,928 with a category attached, or 68.1%. AbbVie accounts for 80.7% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $6,400 and has fallen 79.0% since, to $1,347 in 2024. Among anatomic pathology & clinical pathology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 21 payments — averaging $377.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$6K
- Adaptive Biotechnologies Corporation$1K
- AstraZeneca$100
- Takeda Pharmaceuticals U.S.A., Inc.$99
- Johnson & Johnson$82
- Astellas Pharma US Inc$17
What the payments were for
- Consulting fees$5,40068%
- Travel & lodging$1,85123%
- Food & beverage$6779%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 9 | $6,400 |
| Adaptive Biotechnologies Corporation | 8 | $1,229 |
| AstraZeneca | 1 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $99 |
| Johnson & Johnson | 1 | $82 |
| Astellas Pharma US Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,928 in reported general payments places this provider in the 90th percentile of 736 anatomic pathology & clinical pathology providers in Texas.
See all anatomic pathology & clinical pathology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anatomic pathology & clinical pathology in Houston
- Rabia ShafiHouston$519K
- Jason GregorioHouston$238K
- Sanam LoghaviHouston$94K
- Savitri KrishnamurthyHouston$80K
- Thomas LohmannHouston$30K
- Aysegul SahinHouston$29K
- Lillian GaberHouston$23K
- Ken YoungHouston$23K
- Hong ZhangHouston$22K
- Michelle WilliamsHouston$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.